Autologous Stem Cell Transplantation after Conditioning with Chidamide Plus Carmustine, Etoposide, Cytarabine, and Cyclophosphamide (Chi-BEAC) for Treatment of High-Risk and Relapsed/Refractory Aggressive Lymphoma: Multi-Center, Single-Arm, Open-Label Phase II Clinical Trial

Wei Xu,Yi Xia,Li Wang,Kaiyang Ding,Huayuan Zhu,Maogui Hu,Hua Yin,Jiazhu Wu,Haorui Shen,Jin-Hua Liang,Jianyong Li

Blood（2021）

引用 0|浏览6

暂无评分

摘要

Background:

查看译文

关键词

relapsed/refractory aggressive lymphoma,autologous stem cell transplantation,chidamide plus carmustine,chi-beac,high-risk,multi-center,single-arm,open-label

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要